Your browser doesn't support javascript.
loading
Malignant risk index in evaluation of menopausal ovarian cystic and cystic-solid tumors / 中华全科医师杂志
Article in Chinese | WPRIM (Western Pacific) | ID: wpr-745905
Responsible library: WPRO
ABSTRACT
Clinical data of 349 patients with postmenopausal ovarian cystic and cystic solid tumors undergoing surgical treatment in Beijing Obstetrics and Gynecology Hospital affiliated to Capital Medical University from May 2013 to May 2017 were retrospectively analyzed.Postoperative pathology confirmed 100 cases of malignant tumor,228 cases of benign tumor,and 21 cases of borderline tumor.The malignant risk index (RMI) score was calculated based on the preoperative pelvic ultrasound and serum CA125 level,and the score<200 was classified as benign tumors and ≥200 as malignant tumors.The postoperative pathological results were used as gold standard,the sensitivity,specificity,accurate rate of RMI in diagnosis of malignant tumors was 0.840(84/100),0.987 (225/228) and 94.2% (309/328),respectively.The consistency of RMI with pathological diagnosis was high (Kappa=0.858,P<0.05).The study suggests that RMI has a high degree of credibility for the evaluation of postmenopausal ovarian cystic and cystic solid tumors.

Full text: Available Database: WPRIM (Western Pacific) Type of study: Etiology study Language: Chinese Journal: Chinese Journal of General Practitioners Year: 2019 Document type: Article
Full text: Available Database: WPRIM (Western Pacific) Type of study: Etiology study Language: Chinese Journal: Chinese Journal of General Practitioners Year: 2019 Document type: Article
...